This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Therapeutic Area Partnerships Oncology 2023
May 17-18, 2023
2-Day Digital Conference8:00AM PDT // 1:00PM EDT // 4:00PM BST
Book Now
Menu
Book
keyboard_arrow_right

May 17 - PST/PDT (Pacific Daylight, GMT-7)

keyboard_arrow_leftSearch & Filter
search

May 17 - PST/PDT (Pacific Daylight, GMT-7)

search
08:00 - 08:055 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Welcoming Remarks
  • Patrick Murphy - Digital Events Conference Producer, Informa Connect, UK
08:05 - 08:3530 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Evaluation of multi-cancer early detection technology
  • Hadly Clark - Associate Director, FasterCures, a Centre of the Milken Institute, USA
08:35 - 09:0530 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Invest to stop invasiveness during ovarian cancer diagnosis
  • Oriana Papin-Zoghbi - CEO and Co-founder, AOADX, USA
09:05 - 10:0560 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Discussion on the future of cancer diagnostics. What role will liquid biopsies play?
  • Alessandra Cesano - Chief Medical Officer, ESSA Pharmaceuticals, USA
  • Tom Miller - Founding & Managing Partner, GreyBird Ventures, LLC, USA
  • Hadly Clark - Associate Director, FasterCures, a Centre of the Milken Institute, USA
10:05 - 10:3025 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Break & Networking
    10:30 - 11:3060 mins
    Day 1 - Therapeutic Area Partnerships Oncology 2023
    Discussion with the pros of next-generation sequencing. Is precision medicine the way forward?
    • Anton Buzdin - Chief Scientific Officer, OncoBox, USA
    11:30 - 12:0030 mins
    Day 1 - Therapeutic Area Partnerships Oncology 2023
    Conversation with big pharma; get on board with precision medicine investments
    • Gabriele Allegri - Global Commercial Head - Precision Medicine, The Janssen Pharmaceutical Companies of Johnson & Johnson, USA
    12:00 - 12:3030 mins
    Day 1 - Therapeutic Area Partnerships Oncology 2023
    How to adapt your R&D and clinical strategies to maximise partnership opportunity
    • Jeffrey M. Bockman - Executive Vice President, BioConsulting and Head of Oncology, Lumanity, USA
    12:30 - 13:0030 mins
    Day 1 - Therapeutic Area Partnerships Oncology 2023
    Break & Networking
      13:00 - 13:3030 mins
      Day 1 - Therapeutic Area Partnerships Oncology 2023
      Invest to improve breast cancer chemotherapy treatment
      • Bob Linke - CEO, Osmol Therapeutics, USA
      13:30 - 14:0030 mins
      Day 1 - Therapeutic Area Partnerships Oncology 2023
      Partner with the digital clinic revolutionising cancer survivor patient cancer
      • Hil Moss - Co-Founder/Chief Executive Officer, VivorCare, USA
      NextMay 18
      Filter
      Formats
      Topics
      Choose Day